Tawee Tanvetyanon - Concepedia

Author

Tawee Tanvetyanon

Moffitt Cancer Center ORCID

Also Known As

Chung, Christine H., Dawn E Davies, Ravi, Rajani, T. Tanvetyanon, TAWEE TANVETYANON, Tawee Tanvetyanon

273

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center The University of Texas MD Anderson Cancer Center University of South Florida Memorial Sloan Kettering Cancer Center Fox Chase Cancer Center

About

Tawee Tanvetyanon is an author at Moffitt Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	35	3.5K
2	Health Sciences	10	10	1.6K
3	Public Health	2	2	208
4	Social Sciences	1	1	10
5	Cardiothoracic Surgery	1	1	12

Tawee Tanvetyanon

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network Version 3.2022Advanced Lung DiseaseMedicineCancer ManagementMetastatic Nsclc	2022	1.4K
Non–Small Cell Lung Cancer, Version 4.2024 Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Journal of the National Comprehensive Cancer Network Tumor BiologyActionable Molecular BiomarkersAdvanced Lung DiseaseVersion 4.2024Medicine	2024	614
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023 David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network	2023	449
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial Ben Creelan, Chao Wang, Jamie K. Teer, Nature Medicine Tumor-infiltrating Lymphocyte TreatmentCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2021	400
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer Eric B. Haura, Tawee Tanvetyanon, Alberto Chiappori, Journal of Clinical Oncology	2010	192
Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy in Advanced Non–Small-Cell Lung Cancer George R. Simon, Anupama Sharma, Xueli Li, Journal of Clinical Oncology	2007	181
Prognostic Factors for Survival After Salvage Reirradiation of Head and Neck Cancer Tawee Tanvetyanon, Tapan Padhya, Judith C. McCaffrey, Journal of Clinical Oncology	2009	171
Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements D. Neil Hayes, Amy S. Lucas, Tawee Tanvetyanon, Clinical Cancer Research	2012	149
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology Peter G. Shields, Roy S. Herbst, Douglas A. Arenberg, Journal of the National Comprehensive Cancer Network Tobacco CessationCancer ManagementCancer EducationTobacco ControlOncology	2016	146
Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer Gerold Bepler, Charles C. Williams, Michael J. Schell, Journal of Clinical Oncology	2013	142

Page 1